Quantum量子訊息有限公司
← 最新全球產業報告

Veterinary Tuberculosis Vaccine Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-03-26 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 57 Mn
2033 年預估規模
USD 71 Mn
年複合成長率 CAGR
3.2%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-03-26頁數 152報告編號 CMI5242

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Veterinary Tuberculosis Vaccine Market, By Type (Live Attenuated, Inactivated), By Route of Administration (Sub-cutaneous, Intramuscular, Oral), By Animal Type (Cattle, Dogs, Cats, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly considered as a chronic, debilitating disease, TB occasionally assumes an acute, rapidly progressive course. The disease affects practically all species of vertebrates. The widespread occurrence of multidrug-resistant (MDR) strains and extensively drug-resistant (XDR) strains of M tuberculosis is of concern to clinicians and public health and regulatory officials involved in the control of the disease. Bovine TB is still a significant zoonosis in non-industrialized countries of the world. Signs and lesions are generally similar in the various species. The main types of M tuberculosis complex (mammalian tubercle bacilli) recognized are M tuberculosis, M canettii, M bovis, M caprae, M pinnipedii, M microti, M mungi, and M africanum. The M avium complex includes M avium avium (avian tubercle bacilli), M avium hominissuis (isolated from people, swine, and other mammals), and M intracellular. Market Dynamics Increasing undergoing trial for vaccination is expected to fuel growth of the global veterinary tuberculosis vaccine market over the forecast period. For instance, according to a report published by Multidisciplinary Digital Publishing Institute in June 2020, BCG (Danish) vaccine type is administered by intramuscular to badgers for the prevention of tuberculosis. According to the same source, heat-inactivated Mycobacterium bovis vaccine (HIMB) is administered by intramuscular method to goats for the prevention of tuberculosis Furthermore, increasing awareness programs for veterinary tuberculosis by government authorities is expected to drive growth of the global veterinary tuberculosis vaccine market over the forecast period. For instance, on November 16, 2021, The Welsh Government, U.K. announced the Tuberculosis (TB) Eradication Programme. This program's goal was to offer a TB testing programme in Wales, U.K., in order to further lower the danger of the spread of TB. The Welsh Government, U.K. has advised to make informed purchase selections and to disclose TB information about any cattle they seek to sell. Payments for animals that were killed due to TB, to make sure the method is just and appropriate and takes into account the available funding. Key features of the study • This report provides an in-depth analysis of the global veterinary tuberculosis vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global veterinary tuberculosis vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Merck KGaA, Colorado Serum Company, CZ Vaccines (Zendal), and Zoetis Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global veterinary tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary tuberculosis vaccine market Market Segmentation • By Type o Live Attenuated o Inactivated • By Route of Administration o Sub-cutaneous o Intramuscular o Oral • By Animal Type o Cattle o Dogs o Cats o Others • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players o Merck KGaA o Colorado Serum Company o CZ Vaccines (Zendal) o Zoetis Inc
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type  Market Snapshot, By Route of Administration  Market Snapshot, By Animal Type  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Opportunity o Impact Analysis o Key Developments o Industry Trends o Regulatory Scenario o Recent Product Approval/Launches o PEST Analysis o Porter’s Analysis 4. Global Veterinary Tuberculosis Vaccine Market, By Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Live Attenuated  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Inactivated  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 5. Global Veterinary Tuberculosis Vaccine Market, By Route of Administration, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Sub-cutaneous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Intramuscular  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 6. Global Veterinary Tuberculosis Vaccine Market, By Animal Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Cattle  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Dogs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Cats  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 7. Global Veterinary Tuberculosis Vaccine Market, By Region, 2026 – 2033 (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033(%)  Y-o-Y Growth Analysis, For Regions, 2026 - 2033  Regional Trends o North America  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033 (USD Mn) o U.S. o Canada o Latin America  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033 (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033 (USD Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033 (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033 (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Route of Administration, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Animal Type, 2026 – 2033 (USD Mn)  Market Size and Forecast, By Region/Country, 2026 – 2033 (USD Mn) o South Africa o Central Africa o North Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis  Merck KGaA o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Colorado Serum Company o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  CZ Vaccines (Zendal) o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Zoetis Inc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies o Analyst Views 9. Section o Research Methodology o About Us

提及公司

Merck KGaAColorado Serum CompanyCZ Vaccines (Zendal)Zoetis Inc

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們